{"id":"W4392203306","doi":"10.1016/j.xcrm.2024.101435","title":"Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial","year":2024,"lang":"en","type":"article","venue":"Cell Reports Medicine","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Institute of Cancer Research; Medical Research Council; Manchester Biomedical Research Centre; Ipsen; NIHR Cambridge Biomedical Research Centre; Rosetrees Trust; Royal Marsden NHS Foundation Trust; Department of Health and Social Care; Cancer Research UK; National Institute for Health and Care Research; National Institutes of Health; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Novartis; Melanoma Research Alliance; Francis Crick Institute; Wellcome Trust; Amgen","keywords":"Medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002178926,0.0003807613,0.0008868753,0.0002922099,0.0001315073,0.00003665155,0.0002528022,0.000211078,0.004066422],"category_scores_gemma":[0.002457345,0.0002337965,0.0002125946,0.0008875113,0.0004230885,0.0001029784,0.000173017,0.001086025,0.00004614068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003274576,"about_ca_system_score_gemma":0.0005024236,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005967067,"about_ca_topic_score_gemma":0.0001100131,"domain_scores_codex":[0.9951641,0.00018362,0.001653409,0.001082796,0.001274973,0.0006410963],"domain_scores_gemma":[0.9961165,0.001512292,0.0002952436,0.001542247,0.0001558771,0.0003778515],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.08221851,0.004562158,0.000263904,0.0001828197,0.0002690214,0.03235181,0.008776343,0.00002608406,0.5830948,0.00002971765,0.06547905,0.2227458],"study_design_scores_gemma":[0.1334392,0.01510642,0.0002408881,0.001629776,0.0003248589,0.0005886259,0.001035072,0.0005483988,0.0240102,0.0004176262,0.822308,0.0003509129],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8948732,0.008552894,0.00003577244,0.01596569,0.003666401,0.002705973,0.00003097704,0.0002598175,0.07390931],"genre_scores_gemma":[0.955976,0.0006401535,0.0001619206,0.0006163854,0.0034495,0.00009936869,0.0004998512,0.00009890174,0.03845792],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.756829,"threshold_uncertainty_score":0.996844,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05398573251415962,"score_gpt":0.3569114462957106,"score_spread":0.302925713781551,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}